The Committee for Clinical Studies

The Swedish Research Council’s Committee for Clinical Studies decides on the allocation of the Swedish Research Council’s funds for the national coordination of clinical studies. The Committee has 13 members active within academia, county councils and regions, as well as relevant industry organisations.

Decides on strategic focus and allocation of funds

The Swedish Research Council has been assigned by the Government to support and develop the prerequisites for clinical studies in Sweden through national coordination. The Committee for Clinical Studies decides how the Swedish Research Council’s funds earmarked for the assignment are allocated. The Committee also decides on the strategic focus of the work and promotes work with clinical studies within healthcare, academia and industry.

Strategic plan for the The Committee for Clinical Studies (in Swedish)PDF (pdf, 145.6 kB)

Composition of the Committee

The Committee for Clinical Studies consists of 13 members appointed by the Government, four based on nominations by the Swedish Research Council, four based on nominations by the Swedish Association of Local Authorities and Regions and four based on nominations by the industry organisations for the pharmaceutical industry, the medical technology industry, the biotechnology industry and private healthcare providers.

The committee meets four times a year.

Members 2020

Namn

Titel

Organisation

Chris Heister
(chair)

Chair of the Board

Umeå University

Anders Blanck

Director General

LIF, the Swedish Association of the Pharmaceutical Industry

Johan Dabrosin Söderholm

Professor




Dean

Department of Clinical and Experimental Medicine, Linköping University

 

Faculty of Medicine,

Linköping University

Patrik Danielsson

Professor




Dean

Department of Integrative Medical Biology, Umeå University

 

Faculty of Medicine, Umeå University

Jonas Ekstrand

CEO

SwedenBIO

Annika Bergquist

Acting professor  



Consultant

Department of Medicine, Karolinska Institutet, KI


Karolinska University Hospital

Sune Larsson

Director of Research and Education

Region Uppsala

Anna Lefevre Skjöldebrand

CEO

Swedish Medtech

Hannie Lundgren

Director of Research and Development

 Region Skåne

Jörgen Månsson

Hospital Manager

Carlanderska Hospital

Kerstin Nilsson

Professor



Dean

School of Medical Sciences, Örebro University

 

Faculty of Medicine, Örebro University

Mikael Wiberg

Professor




Director of Research and Education

Department of Integrative Medical Biology, Umeå University


Västerbotten County Council

Katarina Wijk

Professor


Director of Research and Development

University of Gävle


Region Gävleborg

PublISHED ON 29 May 2018

UpDATED ON 12 February 2020

Pdf / Printout

Contact

Contact scientific councils, councils and committees

sark@vr.se

MORE WITHIN THE SAME SUBJECT AREA

  1. Madeleine Durbeej-Hjalt appointed Secretary General for Medicine and Health

    She is a professor of muscle biology and a great advocate for basic researcher-initiated research. But Madeleine Durbeej-Hjalt thinks that one of the most important tasks right now is to consider the ongoing pandemic and its consequences.

  2. 12 million SEK to Clinical Studies Sweden to support COVID-19 studies

    The six regional nodes within Clinical Studies Sweden will each receive a grant of 2 million SEK, or 12 million SEK in total, to strengthen their ability to support clinical studies linked to COVID-19.

  3. Sweden participates in clinical WHO study

    Sweden is participating in a major clinical study conducted by WHO, aimed at testing a number of antiviral medicines on patients around the world who are being treated for COVID-19.